	Predicting acute kidney injury after radical cystectomy for muscle-invasive bladder cancer. BMC Urol Chaker K, Chaabouni A, Elleuch W, Khadhar A, Ouertani K, Chakroun A, Limem A, Laabidi Y, Chedly WB, Ouanes Y, Bibi M, Marrak M, Chelly I, Slimene MH, Nouira Y. PMID: 42907957 [PubMed - indexed for MEDLINE]
	Guidewire-assisted en bloc resection of periorifice non-muscle-invasive bladder cancer: a retrospective case series. BMC Urol Yao Q, Niu H, Jiang H, Xu L, Zang Y, Wu W, Zhu J, Xue B. PMID: 42907801 [PubMed - indexed for MEDLINE]
	Impact of reduced scan extent on tumor detection in (68)Ga-PSMA PET/CT for biochemical recurrence of prostate cancer. BMC Med Imaging Gühne F, Küppers A, Kühnel C, Seifert P, Freesmeyer M. PMID: 42907742 [PubMed - indexed for MEDLINE]
	Computer-Aided Diagnosis of Clinically Significant Prostate Cancer in Transrectal Ultrasound. J Imaging Inform Med Feng Z, Fu J, Zou X, Ye H, Pan H, Li YH, Zhou J, Wang Y. PMID: 42907731 [PubMed - as supplied by publisher]
	Circulating Immune and Cancer Driver Gene Biomarkers Precede Prostate Cancer Diagnosis by over 10 yr. Eur Urol Huang Z, Parsaeian M, Viallon V, Wang Z, Papier K, Desai T, Chan WC, Collister JA, Breeur M, Tong TYN, Cabrera-Castro N, Guevara M, Jimenez-Zabala A, Johansson M, Kolijn PM, Lill CM, Mills IG, Sacerdote C, Tumino R, Zamora-Ros R, Chatterjee N, Platz EA, Ferrari P, Gunter MJ, Riboli E, Atkins JR, Smith-Byrne K, Travis RC. PMID: 42907294 [PubMed - as supplied by publisher]
	Validation of a Computational Histology Artificial Intelligence-based Biomarker for BCG Treatment in Non-muscle-invasive Bladder Cancer in the ANZUP 1301 Randomized Phase 3 Trial. Eur Urol Hayne D, Spalding L, Hawks C, McCombie S, Cheung L, Subhash VV, Krieger L, Ischia J, Anderson P, Srivastav RK, Grummet J, Bastick PA, Krishna V, Kaul G, Zhang H, Krishna V, Sonawane S, Zhang AY, Thomas H, Yip S, Earley A, Oakes S, Lotan Y, Li R, O'Donnell MA, Royce TJ, Joshi A, Redfern AD, Davis ID, Stockler MR. PMID: 42907292 [PubMed - as supplied by publisher]
	Risk-stratified Prostate Cancer Screening in 2026: Blood- and Urine-based Biomarkers. Eur Urol Focus Stangl-Kremser J, Salami SS. PMID: 42907259 [PubMed - as supplied by publisher]
	Clinical Trial of the PRAISE-U Prostate Cancer Screening Algorithm: Update on Cost-effectiveness. Eur Urol Focus Vynckier P, Annemans L, Verhaeghe N, Lindgren P, Fridhammar A, Nilsson K, Van Poppel H, Roobol MJ, Venderbos LDF, Harten MV, van den Bergh RCN, Basu P, Chandran A, Collen S, Galvin D, Tupikowski K, Amorín AG, Vilaseca J, Pata, members of the PRAISE-U consortium. PMID: 42907258 [PubMed - as supplied by publisher]
	Leveraging Digital Histopathology to Build Capacity and Collaboration Toward the Diagnosis of Pediatric Solid Tumors in Mexico. JCO Glob Oncol Angeles Romero AA, Peralta Velazquez V, Barajas F, Rey Helo E, Mercado N, Vázquez Contreras JÁ, Venegas López CS, Bustos Rodriguez FJ, Pozos Ochoa LI, Brunner Cruz MG, Romero Silva L, Chavira Guerrero R, Galván Linares A, Matus Román MT, Gómez Plata E, Valenzuela Espinoza MA, Rodriguez-Galindo C, Friedrich P, Santiago T. PMID: 42906005 [PubMed - indexed for MEDLINE]
	Denosumab Therapy Duration and Osteonecrosis of the Jaw and Skeletal Events in Bone-Metastatic Prostate Cancer. JAMA Netw Open Kim S, Jung S, Bu S, Kim JW, Pyo SW, Lee GJ, Chun SH, Kim IH, Park SS, Choi S. PMID: 42905706 [PubMed - indexed for MEDLINE]
	Initial Enfortumab Vedotin Dose Reduction and Outcomes in Pretreated Advanced Urothelial Carcinoma. JAMA Netw Open Kim IH, Kim CG, Jo J, Jung EH, Park JH, Bae WK, Huh SJ, Choi YJ, Im HS, Lee HJ, Lee K, Lee MY, Park JH, Kim HJ, Song HN, Kim H, Shin SH, Park I. PMID: 42905705 [PubMed - indexed for MEDLINE]
	Changes in Treatment Patterns and Survival Outcomes Across Therapeutic Eras in Metastatic Urothelial Carcinoma: A Multicenter Real-World Study. Int J Urol Tomioka S, Inoue S, Kawase R, Nagasaka Y, Hattori T, Shamoto N, Ito F, Yuguchi Y, Kawanishi H, Maeda M, Tochigi K, Akamatsu S, Zennami K, MEGUMI (MEidai GenitoUrinaryMega Investigation) project. PMID: 42905533 [PubMed - indexed for MEDLINE]
	Clinical and Histopathological Significance of Immunohistochemical Î²-Human Chorionic Gonadotropin (Î²-hCG) Expression in Mononuclear Seminoma Cells. Int J Urol Kalender G, Demirbilek M, , Akku, Özkara H, Y, Önal B, Gürses . PMID: 42905501 [PubMed - indexed for MEDLINE]
	Development and Validation of the JIKEI-YAYOI Score for Predicting Castration Resistance in Metastatic Castration-Sensitive Prostate Cancer Treated With ARSI-Based Doublet Therapy. Int J Urol Urabe F, Ishiyama Y, Fukuokaya W, Fujita N, Sato H, Narita T, Kubo M, Yanagisawa T, Tashiro K, Narita S, Habuchi T, Hatakeyama S, Kimura T, JHA Collaborative Group. PMID: 42905495 [PubMed - indexed for MEDLINE]
	Relative frequency of non-Wilms renal tumours in children: an institutional experience from a national tertiary referral centre in Malaysia. Pediatr Surg Int Othman MY, Nik Ab Aziz NML, Gilbert Fernandez JE, Teh KH, Ismail R, Siah HH, Abdullah MY, Zahari Z. PMID: 42905326 [PubMed - indexed for MEDLINE]
	Zone-specific diagnostic performance of synthetic MRI quantitative parameters, ADC, and PSA density for clinically significant prostate cancer: comparison with PI-RADS v2.1. Int Urol Nephrol Liu Y, Liu X, Zhang H, Liu B, Sun H, Wang T. PMID: 42905210 [PubMed - as supplied by publisher]
	GSTP1 promoter hypermethylation in prostate cancer detection: current evidence, clinical positioning, and translational gaps. Mol Biol Rep Joo JL, Wong RS, Goh BH, Ng NC. PMID: 42905185 [PubMed - indexed for MEDLINE]
	Novel approaches to target prostate cancer stem cells driving therapy resistance and cancer progression. Mol Biol Rep Alatawi FS. PMID: 42905164 [PubMed - indexed for MEDLINE]
	Sleep duration and prostate cancer-specific mortality in the Southern Community Cohort Study. Cancer Causes Control Anukam DC, Nianogo RA, Arah OA, Rao J, Fowke JH, Hashibe M, Zhang ZF. PMID: 42905154 [PubMed - indexed for MEDLINE]
	Multitask Deep Learning Model for Predicting Lymph Node Metastasis and Disease-Free Survival From Cytology Images in Bladder Cancer: A Multicenter Study With Pan-Cytology Validation. Adv Sci (Weinh) Hong G, Jiang F, Xie Y, Huang X, Shen R, Wang Y, Zhu M, Wang H, Yang H, Nie Y, Lin Z, Chen R, Ouyang N, Lin T, Wu S. PMID: 42904771 [PubMed - as supplied by publisher]

Articles 1 - 20 / 182322

Page 1 of 9117



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy